Towards the prophylactic and therapeutic use of human neutralizing monoclonal antibodies for Middle East respiratory syndrome coronavirus (MERS-CoV)

Seiichi Sakamoto, Hiroyuki Tanaka, Satoshi Morimoto

Research output: Contribution to journalEditorialpeer-review

7 Citations (Scopus)
Original languageEnglish
Article number35
JournalAnnals of Translational Medicine
Issue number3
Publication statusPublished - Mar 2015

All Science Journal Classification (ASJC) codes

  • General Medicine

Cite this